Corpus Intelligence IC Memo — COFFEE REGIONAL MEDICAL CENTER 2026-04-26 09:33 UTC
IC Memo — COFFEE REGIONAL MEDICAL CENTER
Investment Committee Memorandum | GA | 82 beds | Grade C | EBITDA uplift $10.4M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

COFFEE REGIONAL MEDICAL CENTER

CCN 110089 | COFFEE, GA | 82 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

COFFEE REGIONAL MEDICAL CENTER is a 82-bed suburban community hospital in COFFEE, GA with $141.6M in net patient revenue and a -10.3% operating margin. The hospital serves a payer mix of 20.7% Medicare, 8.8% Medicaid, and 70.5% commercial.

Thesis: Turnaround. Our ML models identify $10.4M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -10.3% to -2.9% (+736bps).

Net Revenue HCRIS$141.6M
Current EBITDA COMPUTED$-14.6M
Operating Margin COMPUTED-10.3%
Occupancy HCRIS55.1%
Revenue / Bed COMPUTED$1.7M
Net-to-Gross HCRIS26.4%
Distress Probability ML46.6%

2. Market Context & Competitive Position

165
GA Hospitals
-2.8%
State Median Margin
64
Comparable Hospitals

GA has 165 Medicare-certified hospitals with a median operating margin of -2.8%. The target's margin of -10.3% places it below the state median. Among 64 size-comparable peers (41-164 beds), the median margin is -0.5%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (41-164), prioritizing same-state peers. 64 hospitals in the comp set.

HospitalStateBedsRevenueMargin
COFFEE REGIONAL MEDICAL CENTER (Target)GA82$141.6M-10.3%
TANNER MEDICAL CENTER-VILLA RIGA58$289.8M33.3%
PAULDING MEDICAL CENTERGA112$288.5M9.0%
EMORY JOHNS CREEK HOSPITALGA154$269.1M3.5%
SHEPHERD CENTERGA130$254.9M-20.8%
ST MARYS HEALTH CARE SYSTEM IGA161$247.9M3.2%
PIEDMONT ROCKDALE HOSPITALGA141$217.4M-4.1%
DOUGLAS HOSPITALGA112$217.2M-0.8%
NORTHSIDE HOSPITAL - DULUTHGA87$193.2M-3.1%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $10.4M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$3.0M+210bp18mo
Cost to Collect4.5%2.5%$2.8M+200bp12mo
Denial Rate Reduction12.0%6.5%$2.8M+198bp12mo
A/R Days Reduction5200.0%3800.0%$1.7M+122bp9mo
Clean Claim Rate88.0%96.0%$91K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$3.0M
Cost to Collect
$2.8M
Denial Rate Reduction
$2.8M
A/R Days Reduction
$1.7M
Clean Claim Rate
$91K
Total EBITDA Uplift$10.4M
Current EBITDA$-14.6M
+ RCM Uplift+$10.4M
Pro Forma EBITDA$-4.1M
Current Margin-10.3%
Pro Forma Margin-2.9%
WC Released (1x)$5.4M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-22.4M$8.1M0.00x-100.0%
Base (11x exit)10.0x11.0x$-22.4M$1.7M0.00x-100.0%
Bull Case9.0x11.0x$-20.2M$28.8M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-20.2M$25.5M0.00x-100.0%
Bear Case11.0x10.0x$-24.6M$-36.7M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-24.6M$-48.4M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 64 hospitals with 41-164 beds
  • Same-state prioritization (n=65)
  • Comp margins: P25=-13.7% / P50=-0.5% / P75=8.8%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.